CClinicalTrials.gg
CompletedNCT04894084Updated Sep 22, 2023Results posted

Investigation of a Supporting Ostomy Product Intended for Leakage Detection

An interventional study of CP321 in Stoma Ileostomy, sponsored by Coloplast A/S. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-22.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

People with intestinal stomas (especially an ileostomy) can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively.

To overcome this, Coloplast has developed a new supporting ostomy product, which has an adhesive sensor layer that should be place underneath the baseplate normally used by the subject.

Single arm design. Open-labelled Study duration: 21 days + 3 days.

Read the detailed description

Test product is a Digital Leakage Notification System. It consist of a sensor layer (worn beneath the baseplate), a transmitter attached to the sensor layer, a charger for charging of transmitter and an app, to be installed on a smartphone, which notifies the user of the status of their baseplate such as everything looks okay or there is a possible leakage.

Subjects are asked to use test product for 21 days. n=15 were using a phone with Android operating system and n=10 a phone with iOS operating system.

02

Conditions studied

  • Stoma Ileostomy
03

In context

Lead sponsor

Coloplast A/S is the lead sponsor of 146 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Have given written informed consent
  2. Be at least 18 years of age and have full legal capacity
  3. Have had a stoma for more than three months
  4. Have intact skin on the area used in the evaluation meaning no broken skin and only minor discoloration of the skin (assessed by investigator)
  5. Be able to use one of the five sensor layer sizes (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm)
  6. Ileo- or colostomists with liquid output (Bristol scale type 6-7).
  7. Currently using a Coloplast product (1pc/2pc Flat/Convex/Concave) from e.g Assura/SenSura/SenSura Mio
  8. Have self-reported problems with leakage* (three times within 14 days)
  9. Have worry of leakage 'to some, high or very high degree'
  10. Is familiar with the use of a smartphone *Leakage: Leakage is defined as output from the stoma on the backside of the baseplate (underneath the baseplate)

Exclusion criteria

Exclusion Criteria:

  1. Currently receiving or have within the past 2 month received radio- and/or chemotherapy
  2. Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
  3. Are pregnant or breastfeeding
  4. Participating in other interventional clinical investigations or have previously participated in this investigation. Exception: Participation in other Coloplast sponsored clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this protocol.
  5. Known sensitivity towards test product
  6. Known sensitivity towards acrylate
  7. Is using/have a pacemaker
  8. Is using ostomy paste or ostomy powder
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Test product

    Subjects are requested to use the test device (supporting product) beneath their ostomy baseplate. Subjects may change their appliance as they wish, either they may change due to a notification from the app and/or follow their change routine.

    Device: CP321

Interventions

  • DeviceCP321

    The primary objective is to evaluate the system performance of the test product. This is done by asking subjects to answer questions throughout the study

06

What researchers measure

Primary outcomes

  1. System Performance Accuracy of Pictures

    The primary endpoint is system performance accuracy: * True Negative: No leakage observed on picture and no leakage detected by system * True Positive: Leakage observed in picture and leakage detected by system * False Negative: Leakage observed in picture, but no leakage detected by system * False Positive: No leakage observed in picture, but leakage detected by system

    Time frame: 21 days

Secondary outcomes

  1. Frequency of Leakage Onto Clothes Before and After Use of Test Product

    Subjects are asked to recall numbers of leakage events outside baseplate (and/or onto clothes) the past 3 weeks (at baseline and follow-up). Subjects shall give a specific frequency.

    Time frame: At V1 (baseline) and V2 (follow-up, Day 21)

  2. Experience of Leakage Onto Clothes Compared to Only Using Usual Product

    Subject own interpretation, Q: to which degree have you experienced leakage onto your clothes with test product?" (5-point scale: very low degree/not at all, low degree, some degree, high degree, very high degree).

    Time frame: V2 (follow-up, Day 21)

  3. Reliability of Notifications

    Subjects are asked to rate, Q: To which degree did you find notifications from the app reliable and trustworthy (5-point scale; very low degree, low degree, some degree, high degree, very high degree)

    Time frame: V2 (follow-up, Day 21)

  4. Ability to Move With Test Product

    Q: Compared to your usual product, how was your freedom to move with test product? Much better - better - Same - Worse - Much worse

    Time frame: V2 (follow-up, Day 21)

  5. Subjects Worry of Leakage Before and After Use of Test Product

    Q: Think back on the last 3 weeks - to which degree have you worried about leakage? Very high degree - High degree - Some degree - Low degree - Very low degree/Not at all

    Time frame: At V1 (baseline) and V2 (follow-up, Day 21)

  6. Confidence to Avoid Full Leakage With Test Product Compared to Only Using Usual Product

    Q: Compared to your usual product, did you feel confident that you could avoid leakage onto clothes? Yes -No

    Time frame: V2 (follow-up, Day 21)

  7. Confidence in Daily Life Compared to Only Using Usual Product

    Q: Compared to your usual product, to which degree did the test product give you confidence in daily life? Much higher degree- Higher degree- Same degree - Lower degree- Much lower degree

    Time frame: V2 (follow-up, Day 21)

  8. Feeling of Control With Test Product Compared to Only Using Usual Product

    Q: Compared to your usual product, did test product give you a feeling of leakage control? Yes, higher leakage control No, lower leakage control

    Time frame: V2 (follow-up, Day 21)

  9. Control of Leakage Progression With Test Product Compared to Only Using Usual Product

    Q: Compared to your usual product, did the test product give you a feeling of control of leakage progression? Yes, higher control of leakage progression No, lower control of leakage progression

    Time frame: V2 (follow-up, Day 21)

  10. Feeling of Security With Test Product Compared to Only Using Usual Product

    Q: Compared to your usual product, did you feel more or less secure with test product?

    Time frame: V2 (follow-up, Day 21)

  11. Evaluation of Confidence to Increase Social Activities With Test Product Compared to Only Using Usual Product

    Q: Compared with your usual product, did the test product affect your confidence to engage in social activities such as seeing friends, and do physical activities? I felt more confident - I felt less confident

    Time frame: V2 (follow-up, Day 21)

  12. Evaluation of Sleep With Test Product Compared to Only Using Usual Product

    Q: Compared with your usual product, did the test product affect your sleep? Yes, to the better Yes, to the worse No, the same

    Time frame: V2 (follow-up, Day 21)

  13. Confidence at Night With Test Product Compared to Only Using Usual Product

    Compared with your usual product, to which degree did the test product give you confidence at night? Much higher - Higher - Same - Lower - Much lower

    Time frame: V2 (follow-up, Day 21)

  14. Evaluation of Users' Preference

    Q: Which product solution do you prefer? Own product - Own product with test product

    Time frame: V2 (follow-up, Day 21)

  15. Reason for Preference

    Q: What is your reason for preference? (Please tick all that apply) * Body fit * Ability to bend and stretch * Feeling of security * Feeling of confidence * Less fear of leakage onto clothes * Discreet to wear * Discreetness in leakage control * Better sleep * Less embarrassment * Other

    Time frame: V2 (follow-up, Day 21)

  16. Evaluation of Users' Peace of Mind With Test Product

    Q: To which degree did the test product give you peace of mind? Very high degree- High degree- Low degree- Very low degree

    Time frame: V2 (follow-up, Day 21)

  17. To Evaluate Users' Assessment of QoL With Test Product Compared to Usual Product

    Overall, do you think the test product can improve your feeling of control and confidence to avoid leakage onto clothes and therefore improve your quality of life? Yes - No

    Time frame: V2 (follow-up, Day 21)

  18. Adhesive Residue to Skin

    To which degree did you experience adhesive residue to the skin in the area around the transmitter? Very low degree/Not at all - Low degree - Some degree - High degree -Very high degree

    Time frame: V2 (follow-up, Day 21)

  19. Adhesive Residue to Transmitter

    To which degree did you experience adhesive residue on the backside of the transmitter? Very low degree/Not at all - Low degree - Some degree - High degree -Very high degree

    Time frame: V2 (follow-up, Day 21)

07

Results

Posted Aug 1, 2023

Participant flow

Participant flow — Overall Study
MilestoneTest Arm, Intention to Treat
Started25
Completed25
Not completed0

Outcome measures

PrimarySystem Performance Accuracy of Pictures

The primary endpoint is system performance accuracy: * True Negative: No leakage observed on picture and no leakage detected by system * True Positive: Leakage observed in picture and leakage detected by system * False Negative: Leakage observed in picture, but no leakage detected by system * False Positive: No leakage observed in picture, but leakage detected by system

Time frame:
21 days
Reported as:
Count of units · Pictures
System Performance Accuracy of Pictures
PicturesTest Arm, Intention to Treat
True positive122
True negative126
False positive24
False negative45
SecondaryFrequency of Leakage Onto Clothes Before and After Use of Test Product

Subjects are asked to recall numbers of leakage events outside baseplate (and/or onto clothes) the past 3 weeks (at baseline and follow-up). Subjects shall give a specific frequency.

Time frame:
At V1 (baseline) and V2 (follow-up, Day 21)
Reported as:
Least squares mean · Leakage episodes onto clothes
Frequency of Leakage Onto Clothes Before and After Use of Test Product
Leakage episodes onto clothesTest Arm, Intention to Treat
V12.84 (1.69 to 4.76)
V20.51 (0.19 to 1.36)
Statistical analysis
  • Test Arm, Intention to Treat · Poisson loglinear model · p = <0.001 · Risk ratio (rr): 0.18 · 95% CI 0.07 to 0.49
SecondaryExperience of Leakage Onto Clothes Compared to Only Using Usual Product

Subject own interpretation, Q: to which degree have you experienced leakage onto your clothes with test product?" (5-point scale: very low degree/not at all, low degree, some degree, high degree, very high degree).

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Experience of Leakage Onto Clothes Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
Very high degree0
High degree0
Some degree2
Low degree3
Very low degree / Not at all18
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = <0.0001 ("Low degree" + "Very low degree / Not at all" were tested against the rest of the answers in this analysis.) · Exact test in the binomial distribution: 91.3 · 95% CI 72 to 99
SecondaryReliability of Notifications

Subjects are asked to rate, Q: To which degree did you find notifications from the app reliable and trustworthy (5-point scale; very low degree, low degree, some degree, high degree, very high degree)

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Reliability of Notifications
ParticipantsTest Arm, Intention to Treat
Very high degree5
High degree7
Some degree6
Low degree3
Very low degree / Not at all2
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.0106 ("Some degree", "High degree" and "Very high degree" were tested against the rest of the answers in this analysis.) · Exact test in the binomial distribution: 78.3 · 95% CI 56 to 93
SecondaryAbility to Move With Test Product

Q: Compared to your usual product, how was your freedom to move with test product? Much better - better - Same - Worse - Much worse

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Ability to Move With Test Product
ParticipantsTest Arm, Intention to Treat
Much worse0
Worse1
Same16
Better4
Much better2
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = <0.0001 ("Same", "Better" and "Much better" were tested against the rest of the answers in this analysis.) · Exact test in the binomial distribution: 95.7 · 95% CI 78 to 100
SecondarySubjects Worry of Leakage Before and After Use of Test Product

Q: Think back on the last 3 weeks - to which degree have you worried about leakage? Very high degree - High degree - Some degree - Low degree - Very low degree/Not at all

Time frame:
At V1 (baseline) and V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Subjects Worry of Leakage Before and After Use of Test Product
ParticipantsTest Arm, Intention to Treat
V1 — Very high degree1
V1 — High degree11
V1 — Some degree11
V1 — Low degree2
V1 — Very low degree / Not at all0
V2 — Very high degree0
V2 — High degree1
V2 — Some degree6
V2 — Low degree8
V2 — Very low degree / Not at all8
Statistical analysis
  • Test Arm, Intention to Treat · Proportional odds ratio model · p = <0.001
SecondaryConfidence to Avoid Full Leakage With Test Product Compared to Only Using Usual Product

Q: Compared to your usual product, did you feel confident that you could avoid leakage onto clothes? Yes -No

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Confidence to Avoid Full Leakage With Test Product Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
Yes18
No5
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.0106 · Exact test in the binomial distribution: 78.3 · 95% CI 56 to 93
SecondaryConfidence in Daily Life Compared to Only Using Usual Product

Q: Compared to your usual product, to which degree did the test product give you confidence in daily life? Much higher degree- Higher degree- Same degree - Lower degree- Much lower degree

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Confidence in Daily Life Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
Much lower degree1
Lower degree2
Same degree5
Higher degree10
Much higher degree5
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.21 ("Higher degree" and "Much higher degree" were tested against the rest of the answers in this analysis.) · Exact test in the binomial distribution: 65.2 · 95% CI 43 to 84
SecondaryFeeling of Control With Test Product Compared to Only Using Usual Product

Q: Compared to your usual product, did test product give you a feeling of leakage control? Yes, higher leakage control No, lower leakage control

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Feeling of Control With Test Product Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
Yes, higher leakage control18
No, lower leakage control5
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.0106 · Exact test in the binomial distribution: 78.3 · 95% CI 56 to 93
SecondaryControl of Leakage Progression With Test Product Compared to Only Using Usual Product

Q: Compared to your usual product, did the test product give you a feeling of control of leakage progression? Yes, higher control of leakage progression No, lower control of leakage progression

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Control of Leakage Progression With Test Product Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
Yes, higher control of leakage progression16
No, lower control of leakage progression7
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.093 · Exact test in the binomial distribution: 69.6 · 95% CI 47 to 87
SecondaryFeeling of Security With Test Product Compared to Only Using Usual Product

Q: Compared to your usual product, did you feel more or less secure with test product?

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Feeling of Security With Test Product Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
I felt less secure1
I felt more secure22
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = <0.0001 · Exact test in the binomial distribution: 95.7 · 95% CI 78 to 100
SecondaryEvaluation of Confidence to Increase Social Activities With Test Product Compared to Only Using Usual Product

Q: Compared with your usual product, did the test product affect your confidence to engage in social activities such as seeing friends, and do physical activities? I felt more confident - I felt less confident

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Evaluation of Confidence to Increase Social Activities With Test Product Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
I felt less confident2
I felt more confident21
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = <0.0001 · Exact test in the binomial distribution: 91.3 · 95% CI 72 to 99
SecondaryEvaluation of Sleep With Test Product Compared to Only Using Usual Product

Q: Compared with your usual product, did the test product affect your sleep? Yes, to the better Yes, to the worse No, the same

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Evaluation of Sleep With Test Product Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
Yes, to the better8
Yes, to the worse0
No, the same15
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.21 ("Yes, to the better" was tested against the rest of the answers in this analysis.) · Exact test in the binomial distribution: 34.8 · 95% CI 16 to 57
SecondaryConfidence at Night With Test Product Compared to Only Using Usual Product

Compared with your usual product, to which degree did the test product give you confidence at night? Much higher - Higher - Same - Lower - Much lower

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Confidence at Night With Test Product Compared to Only Using Usual Product
ParticipantsTest Arm, Intention to Treat
Much lower degree0
Lower degree1
Same degree11
Higher degree7
Much higher degree4
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 1.00 ("Higher degree" and "Much higher degree" were tested against the rest of the answers in this analysis.) · Exact test in the binomial distribution: 47.8 · 95% CI 27 to 69
SecondaryEvaluation of Users' Preference

Q: Which product solution do you prefer? Own product - Own product with test product

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Evaluation of Users' Preference
ParticipantsTest Arm, Intention to Treat
Own product10
Own product with test product13
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.678 · Exact test in the binomial distribution: 56.5 · 95% CI 34 to 77
SecondaryReason for Preference

Q: What is your reason for preference? (Please tick all that apply) * Body fit * Ability to bend and stretch * Feeling of security * Feeling of confidence * Less fear of leakage onto clothes * Discreet to wear * Discreetness in leakage control * Better sleep * Less embarrassment * Other

Time frame:
V2 (follow-up, Day 21)
Reported as:
Number · Participants
Reason for Preference
ParticipantsTest Arm, Intention to Treat
Preference for test product : Body fit2
Preference for test product : Ability to bend and stretch1
Preference for test product : Feeling of security10
Preference for test product : Feeling of confidence2
Preference for test product : Less fear of leakage onto clothes9
Preference for test product : Discreet to wear2
Preference for test product : Discreetness in leakage control10
Preference for test product : Better sleep5
Preference for test product : Less embarrassment1
Preference for test product : Other0
Preference for own product : Body fit5
Preference for own product : Ability to bend and stretch3
Preference for own product : Feeling of security3
Preference for own product : Feeling of confidence0
Preference for own product : Less fear of leakage onto clothes1
Preference for own product : Discreet to wear3
Preference for own product : Discreetness in leakage control4
Preference for own product : Better sleep0
Preference for own product : Less embarrassment0
Preference for own product : Other1
SecondaryEvaluation of Users' Peace of Mind With Test Product

Q: To which degree did the test product give you peace of mind? Very high degree- High degree- Low degree- Very low degree

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Evaluation of Users' Peace of Mind With Test Product
ParticipantsTest Arm, Intention to Treat
Very high degree6
High degree10
Low degree5
Very low degree2
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.0931 ("High degree" and "Very high degree" were tested against the rest of the answers in this analysis.) · Exact test in the binomial distribution: 69.6 · 95% CI 47 to 87
SecondaryTo Evaluate Users' Assessment of QoL With Test Product Compared to Usual Product

Overall, do you think the test product can improve your feeling of control and confidence to avoid leakage onto clothes and therefore improve your quality of life? Yes - No

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
To Evaluate Users' Assessment of QoL With Test Product Compared to Usual Product
ParticipantsTest Arm, Intention to Treat
No3
Yes20
Statistical analysis
  • Test Arm, Intention to Treat · Exact test in the binomial distribution · p = 0.0005 · Exact test in the binomial distribution: 87.0 · 95% CI 66 to 97
SecondaryAdhesive Residue to Skin

To which degree did you experience adhesive residue to the skin in the area around the transmitter? Very low degree/Not at all - Low degree - Some degree - High degree -Very high degree

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Adhesive Residue to Skin
ParticipantsTest Arm, Intention to Treat
Very low degree/Not at all6
Low degree7
Some degree7
High degree2
Very high degree1
SecondaryAdhesive Residue to Transmitter

To which degree did you experience adhesive residue on the backside of the transmitter? Very low degree/Not at all - Low degree - Some degree - High degree -Very high degree

Time frame:
V2 (follow-up, Day 21)
Reported as:
Count of participants · Participants
Adhesive Residue to Transmitter
ParticipantsTest Arm, Intention to Treat
Very low degree/Not at all9
Low degree5
Some degree9
High degree0
Very high degree0

Adverse events

Collected over 21 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test Product0/25 (0%)0/25 (0%)2/25 (8%)
Most frequent other events
Most frequent other events
EventTest Product
Skin redness and irritationSkin and subcutaneous tissue disorders2/25

Baseline characteristics

Age, Continuous
Age, Continuous(years)Test Arm, Intention to Treat
Mean56 (36 to 80)
Sex: Female, Male
Sex: Female, Male(Participants)Test Arm, Intention to Treat
Female10
Male15
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Test Arm, Intention to Treat
Region of Enrollment
Region of Enrollment(Participants)Test Arm, Intention to Treat
Denmark25
Type of stoma
Type of stoma(Participants)Test Arm, Intention to Treat
Ileostomy15
Colostomy10
08

Study locations

1 site
  • Coloplast A/S
    Humlebæk, 3050, Denmark
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 29, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04894084
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
May 20, 2021
Start date
Apr 29, 2021
Primary completion
Jul 14, 2021
Completion
Jul 14, 2021
Results posted
Aug 1, 2023
Last update
Sep 22, 2023

Study contacts

Søren Meisner, MD
principal investigator · Coloplast A/S

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion